`
`BEFORE THE PATENT TRIAL AND AJ’PEAL BOARD
`
`COALITION FOR AFFORDABLE DRUGS X LLC,
`Petitioner,
`
`ANACOR PHARMACEUTICALS, INC.,
`Patent Owner.
`
`Case No. IPR2015—O1776
`
`Patent No. 7,582,621
`
`PATENT OWNER ANACOR PHARMACEUTICALS, INC.’S
`UPDATED MANDATORY NOTICE
`
`DC: 6008312—1
`
`
`
`Docket No. 036914.0005-US01
`
`IPR2015—01776
`
`Pursuant to 37 C.F.R. § 42.8, Patent Owner Anacor Pharmaceuticals, Inc.
`
`submits the following Updated Mandatory Notices to update the identification of
`
`the real parties—in—interest. All other information remains unchanged.
`
`A.
`
`Real Party-In-Interest Under 37 C.F.R. § 42.8(b)(1)
`
`The real parties—in—interest are Anacor Pharmaceuticals, Inc., Sandoz Inc., and
`
`Pfizer Inc.
`
`All other information previously provided remains the same.
`
`
`Date: October 18 2016
`
`Respectfully submitted,
`
` An rea
`
`. Reist
`
`Registration 0. 36,253
`COVINGTON & BURLING LLP
`
`One CityCenter, 850 Tenth Street, NW
`Washington, DC 20001
`(202) 662-6000
`Attorney for Patent Owner
`
`
`
`CERTIFICATE OF SERVICE
`
`Pursuant to 37 C.F.R. § 42.6, I hereby certify that on this 18th day of October 2016,
`
`the foregoing Patent Owner Anacor Pharmaceuticals, Inc.’s Updated Mandatory
`
`Notice was served by electronic mail, by agreement of the parties, on the following
`
`counsel of record for petitioner.
`
`Jeffrey D. Blake
`Kathleen E. Ott
`
`Peter A. Gergely
`Ryan James Fletcher
`Brent E. Routman
`
`Merchant & Gould PC
`
`KerydinIPR@merchantgould.com
`
`Date: October 18, 2016